United States · FDA National Drug Code directory

Phenazopyridine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2321_55b0c95f-c150-418a-83a9-1708a517d1f5
Product NDC
71335-2321
Form
TABLET
Composition / generic term
Phenazopyridine Hydrochloride
Labeler
Bryant Ranch Prepack
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20231019
Source listing expiry
20261231

Source-listed ingredients

  • PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 9 TABLET in 1 BOTTLE (71335-2321-1) · 71335-2321-1
  • 20 TABLET in 1 BOTTLE (71335-2321-2) · 71335-2321-2
  • 30 TABLET in 1 BOTTLE (71335-2321-3) · 71335-2321-3
  • 10 TABLET in 1 BOTTLE (71335-2321-4) · 71335-2321-4
  • 15 TABLET in 1 BOTTLE (71335-2321-5) · 71335-2321-5
  • 6 TABLET in 1 BOTTLE (71335-2321-6) · 71335-2321-6
  • 90 TABLET in 1 BOTTLE (71335-2321-7) · 71335-2321-7
  • 12 TABLET in 1 BOTTLE (71335-2321-8) · 71335-2321-8
  • 18 TABLET in 1 BOTTLE (71335-2321-9) · 71335-2321-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →